Glycobiology · 2008 · 16 citations · 51 references
Life SciencesBiochemistryMolecular BiologyCarbohydrate BiochemistryCarbohydrate ChemistryGlycobiologyCarbohydrate RecognitionCarbohydrate StructureCarbohydrate-protein InteractionsGlycan RecognitionGlycan StructureGlycan-protein InteractionsCarbohydrate Recognition MotifsCarbohydrate Structural MotifsGlycan Recognition DomainsGlycan Structural AnalysisGlycan Structural MotifsHelicobacter Pylori InfectionHelicobacter Pylori PathogenesisSynthetic Glycan Ligands
Previously we reported binding of Helicobacter pylori to various nonacid and sialylated neolacto carbohydrate structures using a wide range of natural and chemically modified sequences. A novel nonsialylated neolacto-based binding epitope, GlcNAc beta 3Gal beta 4GlcNAc, and analogous structures carrying terminal GalNAc beta 3, GalNAc alpha 3, or Gal alpha 3 showed the binding activity (Miller-Podraza H, Lanne B, Angström J, Teneberg S, Abul-Milh M, Jovall P-A, Karlsson H, Karlsson K-A. 2005. Novel binding epitope for Helicobacter pylori found in neolacto carbohydrate chains. J Biol Chem. 280:19695-19703). The present work reports two other H. pylori-binding nonsialylated neolacto-based structures, GlcA beta 3Gal beta 4GlcNAc beta 3-R and Glc beta 3Gal beta 4GlcNAc beta 3-R, and two amide derivatives (N-methyl and N-ethyl) of GlcA beta 3Gal beta 4GlcNAc beta 3-R which were bound by H. pylori. The latter structures turned out to be more effective as H. pylori binders than the parent saccharide. New reducing-end variants of the neolacto epitope including species containing N-acetyllactosamine linked beta 6 to GlcNAc or Gal with similarity to branched polylactosamines and mucins were prepared and tested. The results extend our previous findings on binding specificities of H. pylori and show that this pathogen is able to interact with an array of N-acetyllactosamine/neolacto structures, which may be of importance for the in vivo interaction of the bacterium with human cells. The information gained in this work may also be of value for rational design of anti-H. pylori drugs.
51
Thomas Borén, Per Falk, Kevin A. Roth et al. · Science · 1993 · 1.2K citations
Structure and Receptor Specificity of the Hemagglutinin from an H5N1 Influenza Virus
James Stevens, Ola Blixt, Terrence M. Tumpey et al. · Science · 2006 · 945 citations
<i>Helicobacter pylori</i> SabA Adhesin in Persistent Infection and Chronic Inflammation
Jafar Mahdavi, Berit Sondén, Marina Hurtig et al. · Science · 2002 · 922 citations · Full text
Keith Brew, Thomas Vanaman, Robert L. Hill · Proceedings of the National Academy of Sciences · 1968 · 461 citations · Full text